- Companies
- Shalby
Shalby Valuation Multiples
Shalby is valued at $149M as of October 2026, a 1.6x revenue multiple. In the last 12 months, Shalby revenue was $128M and Shalby EBITDA was $15M.
Shalby Overview
About Shalby
Shalby Ltd operates a chain of multispecialty hospitals. It is engaged in setting up and managing hospitals and medical diagnostic services. The hospitals offer healthcare services to patients in various areas of specialization such as Cardiology, Emergency Medicine, Gastroenterology Surgery, Arthroscopy Sports Injury, Infectious Diseases, Oncology, and others. The activities are mainly conducted only in India. Revenue mainly comprises fees charged for inpatient and outpatient hospital services. Services include charges for accommodation, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used in treatments given to Patients.
Founded
2004
HQ
Employees
2.8K
Website
Sectors
Financials (LTM)
EV
$203M
Valuation Multiples
Start free trialShalby Financials
Shalby reported last 12-month revenue of $128M and EBITDA of $15M.
In the same LTM period, Shalby generated $15M in EBITDA and $4M in net income.
Revenue (LTM)
Shalby P&L
In the most recent fiscal year, Shalby reported revenue of $118M and EBITDA of $17M.
Shalby is profitable as of last fiscal year, with gross margin of 41%, EBITDA margin of 14%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
Shalby Stock Performance
Shalby has current market cap of $149M, and enterprise value of $203M.
Market Cap Evolution
Shalby's stock price is $1.39.
Shalby share price decreased by 4.1% in the last 30 days.
Shalby has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $203M | $149M | -0.1% | -4.1% | - | - | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialShalby Valuation Multiples
Shalby trades at 1.6x EV/Revenue multiple, and 13.1x EV/EBITDA.
EV / Revenue (LTM)
Shalby Financial Valuation Multiples
As of October 6, 2026, Shalby has market cap of $149M and EV of $203M.
Shalby has a P/E ratio of 39.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Shalby Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Shalby Margins & Growth Rates
Shalby grew revenue by 16% but EBITDA decreased by 7% in the last fiscal year.
In the most recent fiscal year, Shalby reported gross margin of 41%, EBITDA margin of 14%, and net margin of 3%.
Shalby Margins
Shalby Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Shalby Operational KPIs
Shalby's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.
Shalby's Rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Shalby's Rule of X is 44% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Shalby Competitors
Shalby competitors include Athens Medical Centre, Centrum Medyczne ENEL-MED, AirSculpt, Goodwill Pharma, Suraksha Diagnostics, Limes Schlosskliniken, EuroEyes Eye Clinic, Monash IVF Group, Hyperfine and Tınaztepe Sağlık.
Most Shalby public comparables operate across Hospitals & Clinics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $310M | $31M | 1.1x | - | 11.2x | - | |||
| $219M | $28M | 1.1x | - | 8.4x | - | |||
| $152M | $1M | 1.3x | 1.3x | 153.3x | 14.6x | |||
| $70M | $18M | 2.8x | - | 10.7x | - | |||
| $32M | $10M | 5.9x | 5.4x | 19.1x | 17.1x | |||
| $56M | $14M | 3.5x | 2.8x | 13.6x | 11.6x | |||
| $101M | $29M | 0.8x | - | 2.7x | - | |||
| $189M | $45M | 1.8x | 1.7x | 7.4x | 8.7x | |||
This data is available for Pro users. Sign up to see all Shalby competitors and their valuation data. Start Free Trial | ||||||||
Shalby VC Funding History
Before going public, Shalby raised $23M in total equity funding, across 1 round.
Last private valuation of Shalby was $236M, after raising $23M in December 2017.
Shalby Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Shalby
| When was Shalby founded? | Shalby was founded in 2004. |
| Where is Shalby headquartered? | Shalby is headquartered in India. |
| How many employees does Shalby have? | As of today, Shalby has over 2K employees. |
| Is Shalby publicly listed? | Yes, Shalby is a public company listed on Bombay Stock Exchange. |
| What is the stock symbol of Shalby? | Shalby trades under 540797 ticker. |
| When did Shalby go public? | Shalby went public in 2017. |
| Who are competitors of Shalby? | Shalby main competitors include Athens Medical Centre, Centrum Medyczne ENEL-MED, AirSculpt, Goodwill Pharma, Suraksha Diagnostics, Limes Schlosskliniken, EuroEyes Eye Clinic, Monash IVF Group, Hyperfine, Tınaztepe Sağlık. |
| What is the current market cap of Shalby? | Shalby's current market cap is $149M. |
| What is the current revenue of Shalby? | Shalby's last 12 months revenue is $128M. |
| What is the current revenue growth of Shalby? | Shalby revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Shalby? | Current revenue multiple of Shalby is 1.6x. |
| What is the current EBITDA of Shalby? | Shalby's last 12 months EBITDA is $15M. |
| What is Shalby's EBITDA margin? | Shalby's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Shalby? | Current EBITDA multiple of Shalby is 13.1x. |
| What is the current FCF of Shalby? | Shalby's last 12 months FCF is ($3M). |
| What is Shalby's FCF margin? | Shalby's last 12 months FCF margin is (2%). |
| What is the current EV/FCF multiple of Shalby? | Current FCF multiple of Shalby is (64.4x). |
| How many companies Shalby has acquired to date? | Shalby hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Shalby has invested to date? | Shalby hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Shalby
Lists including Shalby
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




